Startseite UB

Safety and feasibility of third-party multipotent adult progenitor cells for immunomodulation therapy after liver transplantation - a phase I study (MISOT-I).

Popp, Felix C. and Fillenberg, Barbara and Eggenhofer, Elke and Renner, Philipp and Dillmann, Johannes and Benseler, Volker and Schnitzbauer, Andreas A. and Hutchinson, James and Deans, Robert and Ladenheim, Deborah and Graveen, Cheryl A and Zeman, Florian and Koller, Michael and Hoogduijn, Martin J and Geissler, Edward K. and Schlitt, Hans J. and Dahlke, Marc H. (2011) Safety and feasibility of third-party multipotent adult progenitor cells for immunomodulation therapy after liver transplantation - a phase I study (MISOT-I). Journal of translational medicine 9 (1), p. 124.

[img]
Preview
License: Creative Commons Attribution
PDF - Published Version
Download (880kB)

at PubMed

at publisher (via DOI)


Abstract

BACKGROUND: Liver transplantation is the definitive treatment for many end-stage liver diseases. However, the life-long immunosuppression needed to prevent graft rejection causes clinically significant side effects. Cellular immunomodulatory therapies may allow the dose of immunosuppressive drugs to be reduced. In the current protocol, we propose to complement immunosuppressive pharmacotherapy ...

plus


Export bibliographical data



Item Type:Article
Date:2011
Institutions:Medicine > Lehrstuhl für Chirurgie
Projects:Open Access Publizieren (DFG)
Identification Number:
ValueType
21798013PubMed ID
10.1186/1479-5876-9-124DOI
Subjects:600 Technology > 610 Medical sciences Medicine
Status:Published
Refereed:Yes, this version has been refereed
Created at the University of Regensburg:Partially
Owner: Universitätsbibliothek Regensburg
Deposited On:09 Sep 2011 09:46
Last Modified:13 Mar 2014 17:58
Item ID:21897
Owner Only: item control page

Downloads

Downloads per month over past year

  1. University

University Library

Publication Server

Contact person
Gernot Deinzer

Telefon 0941 943-2759
Contact